Relationship [qlco]
Apolipoprotein E [aapp, bacs]
Polymorphism [genf]
menopausal symptoms [sosy]
Serum lipids NOS [lbpr]
Hormone replacement therapy [topp]
Objective [inpr]
Menopausal [phsf]
Women [popg]
Receive [qlco]
Hormone replacement therapy [topp]
relieve [ftcn]
symptoms [ftcn]
Help [socb]
PREVENT [phsu]
Osteoporosis [dsyn]
atherosclerotic [ftcn]
investigated [ftcn]
Association [menp]
Apolipoprotein E [aapp, bacs]
Polymorphism [genf]
menopausal symptoms [sosy]
Body fat mass [orga]
Lipid [lipd]
Profile [lbpr]
Women [popg]
Lipid [lipd]
Hormone replacement therapy [topp]
Administration [ocac]
Women [popg]
postmenopausal [tmco]
Study Design [resa]
Subject [grup]
divided [ftcn]
Group [idcn]
Apolipoprotein E phenotype [lbtr]
Group [idcn]
E2 [gngm]
Apolipoprotein E2 [aapp, bacs]
2-3 [resa]
Group [idcn]
E3 [gngm]
Apolipoprotein E-3 [aapp]
Group [idcn]
E4 [gngm]
Apolipoprotein E-4 [aapp]
Typical [qlco]
menopausal symptoms [sosy]
Classified [clas]
degrees [qnco]
Severity [qlco]
Body fat mass [orga]
Lipid [lipd]
Profile [lbpr]
Serum lipid levels [lbpr]
Measured [qlco]
months [tmco]
Oral [spco]
Hormone replacement therapy [topp]
symptoms [ftcn]
Group [idcn]
Apolipoprotein E [aapp, bacs]
Highest [qlco]
Group [idcn]
E2 [gngm]
Lowest [qlco]
Group [idcn]
E4 [gngm]
Seen [qlco]
Levels [qlco]
Total Cholesterol [lbpr]
Low Density Lipoprotein Cholesterol [bacs, strd]
Apolipoprotein B [aapp, bacs]
Group [idcn]
E4 [gngm]
Highest [qlco]
Levels [qlco]
Group [idcn]
E2 [gngm]
Lowest [qlco]
Triglyceride level [lbtr]
TG [lbpr]
Highest [qlco]
Group [idcn]
E2 [gngm]
Not significant [fndg]
Parameters [fndg]
Suggest [idcn]
Group [idcn]
E4 [gngm]
High Risk [qlco]
Cardiovascular disease [dsyn]
Low Density Lipoprotein Cholesterol [bacs, strd]
High Density Lipoprotein Cholesterol [bacs, lipd]
Ratio [qnco]
Improved [qlco]
Hormone replacement therapy [topp]
Hormone replacement therapy [topp]
Group [idcn]
E2 [gngm]
Group [idcn]
E3 [gngm]
Group [idcn]
E4 [gngm]
Apolipoprotein E phenotype [lbtr]
menopausal symptoms [sosy]
Group [idcn]
E4 [gngm]
High Risk [qlco]
Cardiovascular disease [dsyn]
Group [idcn]
E2 [gngm]
Lowest [qlco]
Oral [spco]
Hormone replacement therapy [topp]
Recommended [idcn]
Women [popg]
Group [idcn]
E4 [gngm]
Science [ocdi]
Ireland [geoa]
LTD [ortf]
